Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AVE0010 dose-escalation study in Japanese and Caucasian adults with type 2 diabetes mellitus
2006-003138-13Phase 2Completed
- Sponsor
- Sanofi
- Start
- Aug 2006
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing AVE0010 with Placebo (2 arms). Started Aug 2006; status: completed.
02
Drugs
lixisenatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2006-003138-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003138-13.